ArticlePharmacology research & perspectives2026
Duplicate Prescription Patterns in Patients With Substance Use Disorders.
Article in Pharmacology research & perspectives, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Medication-safety burden of omeprazole in psychiatric inpatients: A retrospective cross-sectional study.The Journal of international medical research · 2026Article
- Duplicate Prescription Patterns in Patients With Substance Use Disorders.Pharmacology research & perspectives · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study sought to investigate the frequency and characteristics of duplicate prescriptions (DPs) in psychiatric inpatients with substance use disorders using a DP classification that differentiates between appropriate DPs (ADPs) and potentially inappropriate DPs (PIDPs). The study was conducted as a monocentric retrospective cross-sectional study on the addiction-specific ward of the Department of Psychiatry, Social Psychiatry and Psychotherapy of Hannover Medical School, a large university hospital in northern Germany. The outcome measures were the nature and frequency of PIDPs compared with ADPs. Medication records of 1174 patients enrolled between January 2016 and December 2021 were reviewed. The median age of the study population (27.8% female) was 48 years (interquartile range (IQR) 39-56). Patients took a median of 4 drugs (IQR 2-6). 12.8% of the study population were exposed to at least one PIDP (at least one grade-1 PIDP: 12.0%; at least one grade-2 PIDP: 1.3%; at least one grade-3 PIDP: 0.3%). Sedatives were the most common cause of grade-1 PIDPs, while grade-2 PIDPs were elicited predominantly by opioids. Nearly one third of the study population (29.0%) displayed at least one ADP. Physicians treating patients with substance use disorders should carefully monitor for PIDPs, particularly PIDPs elicited by sedatives and opioids. Addressing PIDPs may help prevent adverse drug reactions and reduce drug expenses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.